AI scribes have crossed into the veterinary mainstream. The next question is implementation.

Direct answer

AI scribing is no longer a speculative veterinary technology. It has moved from "interesting tool" to common clinical-workflow software, especially in companion-animal practice. The best available market data now suggests roughly half of surveyed U.S. and Canadian companion-animal practices have at least one AI scribe user, and nearly half of surveyed clinical staff personally use one for at least some appointments.

That does not mean the category is solved. It means the basic use case is now well understood: record or dictate the visit, generate a structured medical note, have the veterinarian review it, then move it into the medical record. The remaining questions are less about whether AI scribes work at all and more about accuracy, review burden, consent, data privacy, PIMS integration, and whether the tool actually fits the clinic's workflow (AAHA).

TL;DR

AI scribes are approaching commodity status at the product level, but not at the workflow level. Dozens of tools can now produce a SOAP note. Fewer can do it in the clinic's preferred format, with reliable handling of false positives and false negatives, clear data-use terms, minimal copy-paste, and adoption across the whole care team.

The winning implementation model is simple: pilot the tool, measure edits and time saved, define consent and privacy rules, train the team, and keep the veterinarian responsible for the final record.

What the surveys show

One 2026 North American companion-animal software survey found that 46.6% of surveyed clinical staff personally use an AI scribe at least some of the time, while 50% of surveyed practices reported at least one scribe user. Adoption was higher in Canada than in the United States, and corporate practices reported higher adoption than independents. The survey excluded Mars Veterinary Health practices, and the English-speaking Canadian sample excluded Québec — so read it as a strong market signal rather than a perfect census.

The broader AI baseline was already forming in 2024. A Digitail/AAHA survey of 3,968 veterinary professionals found that 39.2% used AI tools or software in a veterinary setting, with common applications including imaging, administrative tasks, and voice-to-text transcription. That same survey identified accuracy/reliability and data security/privacy as the leading concerns (dvm360).

The product market is now crowded enough that price and packaging are buyer issues. A 2026 vendor-neutral pricing comparison listed 12 veterinary AI scribe tools, with models ranging from free limited tiers to per-user, per-DVM, usage-capped, and flat clinic-rate pricing (VetSoftwareHub).

Regulators are catching up too. The AAVSB's 2025 AI white paper says licensees must understand the risks and limitations of AI, maintain transparency, protect client data privacy, and obtain informed consent when appropriate. It also emphasizes that the veterinarian or veterinary facility remains responsible for decisions and errors arising from AI use.

What changed

For the first wave of veterinary AI, diagnostic imaging got most of the attention. It had a clean input, a narrow output, and a clear second-opinion role. Scribing followed a different path. It entered through a pain point every clinic already understood: medical records.

Veterinarians do not need to be convinced that documentation is a burden. They need to know whether a tool can reduce that burden without creating new risk. That is why AI scribes have spread faster than many other AI applications. They do not ask the clinician to change the appointment. They listen to the appointment and produce a draft record.

That makes scribing different from clinical decision support. A radiology AI tool may influence interpretation. A predictive model may affect risk assessment. A scribe mostly changes the documentation layer. The doctor still sees the patient, talks to the client, makes the diagnosis, chooses the plan, and signs the record.

That distinction explains both the adoption and the limits. Scribes are easier to trial because they sit beside the clinical workflow. But they are still medical-record tools, and a wrong note can still create clinical, legal, or client-communication risk.

Where adoption stands now

The useful way to think about the market:

• Awareness is no longer the bottleneck. Most practice owners and clinicians have now heard of AI scribes.
• Availability is no longer the bottleneck. Clinics can choose from standalone veterinary scribes, dictation-first tools with AI note generation, PIMS-adjacent offerings, and newer low-cost or free-entry products (VetSoftwareHub).
• Implementation is the bottleneck. The hard part is not finding a vendor. It is getting clean usage across doctors, technicians, exam rooms, species, appointment types, templates, client-consent preferences, and the practice-management system.

That is where the category is heading. The next competitive fight is not "Can your AI write a SOAP note?" It is "Can your AI become part of the record workflow without adding friction?"

What practices should do

For veterinarians. Use the scribe as a draft, not a witness. Review the note while the visit is still fresh. The most important errors to watch for are not typos; they are clinical-meaning errors. AAHA's implementation discussion highlights false positives and false negatives as key risks: the tool may add something that was ruled out, or omit something that needed monitoring.

For practice owners and managers. Do not buy on demo quality alone. Run a real pilot across appointment types: wellness, urgent care, chronic disease, euthanasia, surgery discharge, multi-pet visits, noisy rooms, and visits with emotionally distressed clients. Track how many minutes the tool saves — but also how many edits the doctor makes before signing.

For technicians. Expect the workflow to involve the whole care team. Some adoption data shows veterinary technicians using scribes at nearly the same rate as veterinarians, which suggests this is becoming a clinical-team tool rather than a doctor-only productivity app.

For clients. The client-facing issue is transparency. Practices should be ready to explain whether the appointment is being recorded, how the recording is used, whether it is stored, who can access it, and whether the client can opt out. AAVSB guidance points directly to transparency, privacy, and informed consent.

For vendors. The market is maturing. A generic SOAP-note generator is not enough. The durable value is likely to come from better veterinary-specific templates, lower correction burden, a trusted privacy posture, specialty workflows, patient-history context, and direct PIMS write-back.

Implementation checklist

Before signing with an AI scribe vendor, clinics should be able to answer:

• Accuracy: How does the tool handle ruled-out diagnoses, uncertain language, differentials, client-reported history, and multi-pet conversations?
• Review: Who reviews the note, when, and what must be checked before it enters the medical record?
• Consent: What will clients be told? Is consent verbal, written, opt-in, or opt-out? Does the clinic's jurisdiction require anything specific?
• Privacy: Are recordings stored, and for how long? Can the vendor use clinic data to train models? Who can access transcripts and generated notes?
• PIMS workflow: Does the note write back directly, or does the team copy and paste? Are there integration fees?
• Templates: Can the tool match the clinic's actual SOAP style, discharge style, dental notes, surgery notes, and specialty workflows?
• Metrics: During the pilot, measure time saved, edit burden, adoption by clinician, note completion time, client objections, and any corrections after records are finalized.

What "commoditization" really means

AI scribing is approaching commoditization the way many software categories do: the basic function is becoming common, pricing is visible, free trials are expected, and buyers can compare multiple products quickly (VetSoftwareHub).

But the category is not fully commoditized where it matters most. A scribe that saves 45 minutes for one doctor and creates 20 minutes of cleanup for another is not a commodity. A tool that works in wellness visits but fails in emergency, specialty, equine, or noisy exam rooms is not interchangeable. A product with weak data terms is not the same as one a medical director can defend.

The commodity is "AI can draft a note." The product is "this clinic can trust this workflow."

Bottom line

AI scribing has become the first generative-AI application in veterinary medicine to show broad, practical adoption — because it solves a painful, familiar problem without asking the veterinarian to hand over clinical judgment.

The next phase will be less exciting but more important: governance, consent, accuracy monitoring, PIMS integration, and clinic-specific workflow design. Practices that treat scribes as plug-and-play transcription apps will get uneven results. Practices that treat them as medical-record infrastructure will get the real benefit — fewer late-night records, cleaner notes, and more clinician time returned to patient care.